MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

DSpace Repositorium (Manakin basiert)

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

Autor(en): Sledge, George W., Jr.; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Inoue, Kenichi; Pivot, Xavier; Burdaeva, Olga; Okera, Meena; Masuda, Norikazu; Kaufman, Peter A.; Koh, Han; Grischke, Eva-Maria; Frenzel, Martin; Lin, Yong; Barriga, Susana; Smith, Ian C.; Bourayou, Nawel; Llombart-Cussac, Antonio
Tübinger Autor(en):
Grischke, Eva-Maria
Erschienen in: Journal of Clinical Oncology (2017), Bd. 35, H. 25, S. 2875-
Verlagsangabe: Amer Soc Clinical Oncology
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1200/JCO.2017.73.7585
ISSN: 1527-7755
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: